uploads/2017/12/Orthopedic.png

Inside Johnson & Johnson’s Orthopedic Medical Devices Performance in 3Q17

By

Updated

Hip devices revenue trends

In 3Q17, Johnson & Johnson’s (JNJ) hip medical devices generated revenues of $328 million, which reflected a ~2% YoY (year-over-year) rise and a 6% QoQ (quarter-over-quarter) rise.

In 3Q17, in the US and in international markets, hip medical devices generated revenues of $195 million and $133 million, respectively, compared with $190 million and $130 million in 3Q16.

Hip medical devices reported revenues of $1.03 billion for the first nine months of 2017, compared with $1.01 billion during the corresponding period of 2016.

Knee medical devices

In 3Q17, JNJ’s knee medical devices reported revenues of $343 million, which represents a ~3% YoY fall and an 11% QoQ fall. In 3Q17, in the US and in international markets, knee medical devices generated revenues of $220 million and $123 million, respectively, compared with $223 million and $132 million in 3Q16.

Knee medical devices reported revenues of $1.13 billion for the first nine months of 2017, reflecting a ~0.3% YoY decline.

Trauma medical devices

In 3Q17, JNJ’s trauma medical devices reported revenues of $662 million, which is ~4% higher on a YoY basis and 3% higher QoQ. In 3Q17, in the US and in international markets, trauma medical devices reported revenues of $398 million and $264 million, respectively, compared with $389 million and $248 million in 3Q16.

Trauma medical devices reported revenues of $1.9 billion for the first nine months of 2017, which was ~1.7% higher YoY.

Spine medical devices

In 3Q17, JNJ’s spine medical devices generated revenues of $918 million, which was ~2% lower YoY and 5% lower QoQ. In 3Q17, in the US and in international markets, Trauma medical devices generated revenues of $513 million and $405 million, respectively, compared with $541 million and $398 million in 3Q16.

Spine medical devices reported revenues of $2.82 billion for the first nine months of 2017, compared with $2.89 billion during the corresponding period of 2016.

In 3Q17, orthopedic medical device market peers Wright Medical Group (WMGI), Stryker Corporation (SYK) and NuVasive (NUVA) reported revenues of $170 million, $3.0 billion, and $247 million, respectively.

Notably, the iShares Global Healthcare ETF (IXJ) invests ~8.17% of its total portfolio holdings in JNJ.

More From Market Realist